John C Longhurst Selected Research

John C Longhurst Research Topics

Disease

9	Myocardial Ischemia (Ischemic Heart Diseases) 07/2013 - 01/2002
7	AIDS-Related Complex (ARC) 11/2010 - 06/2006
5	Bradycardia 01/2018 - 03/2011
5	Hypertension (High Blood Pressure) 10/2017 - 01/2012
5	Ischemia 07/2013 - 01/2002
2	Myocardial Infarction 12/2012 - 01/2009
1	Syncope (Fainting) 01/2018
1	Infarction (Infarctions) 12/2012
1	Hypotension (Low Blood Pressure) 04/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Unstable Angina 01/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2008
1	Abnormal Reflex (Hyperreflexia) 03/2005

Drug/Important Bio-Agent (IBA)

7	BradykininIBA 07/2013 - 07/2003
5	Opioid Analgesics (Opioids)IBA 01/2018 - 06/2006
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2012 - 06/2006
3	Kainic Acid (Kainate)IBA 04/2012 - 06/2006
2	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 07/2013
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 07/2013
2	EnkephalinsIBA 10/2016 - 08/2007
2	gamma-Aminobutyric Acid (GABA)IBA 12/2014 - 04/2012
2	Opioid Peptides (Opioid Peptide)IBA 07/2013 - 08/2007
2	Adenosine Triphosphate (ATP)IBA 07/2013 - 12/2010
2	ThromboxanesIBA 01/2010 - 01/2009
2	Thromboxane A2 (A2, Thromboxane)IBA 01/2010 - 12/2008
2	beta-Endorphin (Endorphin, beta)IBA 02/2009 - 08/2007
2	homocysteic acidIBA 02/2009 - 06/2006
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2009 - 02/2005
2	Serotonin (5 Hydroxytryptamine)IBA 01/2009 - 01/2002
1	phenyl biguanideIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 10/2017
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2014
1	Sincalide FDA Link 08/2013
1	Narcotic Antagonists (Opioid Antagonists)IBA 07/2013
1	gabazineIBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 03/2013
1	Plant ExtractsIBA 12/2012
1	triphenyltetrazoliumIBA 12/2012
1	Coloring Agents (Dyes)IBA 12/2012
1	AngiotensinsIBA 01/2012
1	methyl bromide (bromomethane)IBA 03/2011
1	Atropine FDA LinkGeneric 03/2011
1	Atenolol (Tenormin)FDA LinkGeneric 03/2011
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 12/2010
1	salicylhydroxamic acid (SHAM)IBA 11/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009
1	Hydroxyl RadicalIBA 01/2009
1	Protons (Proton)IBA 01/2009
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2009
1	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2008
1	sulotrobanIBA 12/2008
1	ProstaglandinsIBA 12/2008
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 12/2008
1	Kynurenic Acid (Kynurenate)IBA 12/2007
1	Glutamic Acid (Glutamate)FDA Link 08/2007
1	Vesicular Glutamate Transport ProteinsIBA 08/2007
1	Excitatory Amino AcidsIBA 06/2006
1	Pyrilamine (Mepyramine)FDA Link 02/2005
1	Inosine Monophosphate (IMP)IBA 02/2005
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 02/2005
1	AutacoidsIBA 02/2005

Therapy/Procedure

16	Electroacupuncture 01/2018 - 07/2003
6	Acupuncture Points (Acupuncture Point) 01/2018 - 07/2003
1	Controlled Hypotension 04/2012
1	Microspheres (Microsphere) 11/2010
1	Therapeutics 01/2009
1	Aftercare (After-Treatment) 01/2002